@ARTICLE{
author={Sheitanov Y,Povoroznyuk V,Dimic Aleksandar N,Bookbinder S,George M,Gauler G,von Hinuber U,Walker D,Braun Juergen,Fear S,Fritchley S,Tansley R,Baker H},
year={2007},
title={A phase II randomized, double-blind, multicenter, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of three strengths of ad 452 in adult subjects with active rheumatoid arthritis},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={66},
number={},
pages={448-448},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Pilipovic Nada,Damjanov Nemanja S,Petrovic Radmila R,Radunovic Lazar,Dimic Aleksandar N,Huber B,Kirkpatrick James C,Baker H,TansleY R,Sharpington T},
year={2006},
title={A randomized, double-blind, placebo controlled dose ranging, parallel study to compare the safety, tolerability and pharmacokinetics of 3 doses of AD 452 in adult subjects with rheumatoid arthritis on a background of stable DMARD therapy.},
journal={ARTHRITIS AND RHEUMATISM},
volume={54},
number={9},
pages={S412-S412},
document_type={Meeting Abstract},
}